Navigation Links
Bayer Wins Positive Response For Marketing Its Cancer Drug

European officials have given the green signal for Bayer AG and its partner Onyx Pharmaceuticals Inc., for marketing their new drug to treat kidney cancer//.

The opinion of the European Committee for Medicinal Products for Human Use (CHMP) of the drug Nexavar would now be passed onto the European Commission.

A positive ruling by the commission could pave the way for a marketing authorisation for all EU nations in the second half of this year.

The announcement coincided with Bayer's annual general meeting in Cologne, where the group's chief Werner Wenning sought to secure shareholders' support for the planned 16.5 billion euros ($21 billion) takeover of rival pharmaceuticals firm Schering AG.

Describing the proposed acquisition as a milestone in the company's history, Wenning said that this move was the "right step" for the group.

The takeover, Wenning said, would propel Bayer into "the top league of pharmaceutical makers around the world".

Wenning went on to tell the company's shareholders that the acquisition would result in the health services section emerging as the key engine for growth.

Bayer's 86-euro a share offer for Berlin based Schering runs until the end of May with the takeover representing the biggest acquisition in Bayer's corporate history.

--Edited IANS
'"/>




Page: 1

Related medicine news :

1. Bayer Voluntarily Withdraws BAYCOL - A Drug Associated With 50 Deaths
2. Genomatix Licensed By Bayer Healthcare
3. Bayer to Market Biocon Insulin in China
4. Test for Esophageal Reflux Licensed to Bayer by University
5. The Positive Effects Of A Healthy Lifestyle
6. The Positive Effects Of A Healthy Lifestyle
7. Positive Thinking
8. Ruling On Non Disclosure Of HIV Positive Status Is Not Ethical
9. Controversy Surrounding The HIV Positive Reports Of One-Year Girl In Kerala
10. HIV Positive People Touching 60,000 In UK
11. Russian Miss HIV Positive Says Victims Are Treated Like Prostitutes
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/26/2016)... NC (PRWEB) , ... June 26, 2016 , ... Brent Kasmer, a legally blind and ... to be personalized through a fitness app. The fitness app plans to fix the two ... currently only offer a one size fits all type program , They don’t ...
(Date:6/25/2016)... ... 2016 , ... The temporary closing of Bruton Memorial Library on June 21 due to a ... new, often overlooked aspect of head lice: the parasite’s ability to live away from a ... occurrence, but a necessary one in the event that lice have simply gotten out of ...
(Date:6/25/2016)... ... June 25, 2016 , ... ... recover from injury. Recently, he has implemented orthobiologic procedures as a method for ... is one of the first doctors to perform the treatment. Orthobiologics are substances ...
(Date:6/24/2016)... ... ... Those who have experienced traumatic events may suffer from a complex set ... drug or alcohol abuse, as a coping mechanism. To avoid this pain and suffering, ... traumatic event. , Trauma sufferers tend to feel a range of emotions, from depression, ...
(Date:6/24/2016)... ... 24, 2016 , ... Global law firm Greenberg Traurig, P.A. announced that 20 ... by their peers for this recognition are considered among the top 2 percent of ... honors as members of this year’s Legal Elite Hall of Fame: Miami Shareholders ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... June 23, 2016 Research and Markets ... Market - Forecast to 2022" report to their offering. ... method for the patients with kidney failure, it replaces the ... from the patient,s blood and thus the treatment helps to ... chloride in balance. Increasing number of ESRD ...
(Date:6/23/2016)...  In a startling report released today, National Safety Council ... a comprehensive, proven plan to eliminate prescription opioid overdoses. ... states are tackling the worst drug crisis in recorded U.S. history, ... Kentucky , New Mexico , ... the 28 failing states, three – Michigan , ...
(Date:6/23/2016)... LOS ANGELES , June 23, 2016 /PRNewswire/ ... (NASDAQ: CAPR ), a biotechnology company ... first-in-class therapeutics, today announced that patient enrollment in ... progrEssion in Duchenne) has exceeded 50% of its ... its enrollment in the third quarter of 2016, ...
Breaking Medicine Technology: